Agenda

ATMP Sweden 2026 brings academia, healthcare and industry together around a single question: what needs to change for advanced therapies to reach patients at scale?

Over two days the programme covers emerging science from Swedish and Nordic research groups, regulatory and manufacturing routes that carry it toward the clinic, the trial infrastructure and capability that puts it in front of patients, and the funding and reimbursement models that decide whether it stays there. Throughout it all are the translational journeys behind the field, successes and failures alike, and the patient voices that gives the work purpose.

The agenda is still taking shape – session names, timing, and other details are subject to change.